MANCHESTER KEITH S 4

What Happened
Keith S. Manchester, a director of Roivant Sciences Ltd. (ROIV), sold a total of 1,225,784 common shares in a series of open-market dispositions between Feb 11 and Feb 13, 2026. The sales were executed in five transactions at prices ranging from $26.49 to $26.76 per share, generating aggregate proceeds of $32,658,518. These were sales (not purchases or option exercises).

Key Details

• Transactions (date — shares @ price — proceeds):
  • 2026-02-11 — 425,000 @ $26.67 = $11,334,750
  • 2026-02-12 — 150,000 @ $26.72 = $4,008,000
  • 2026-02-12 — 275,000 @ $26.76 = $7,359,000
  • 2026-02-13 — 150,784 @ $26.49 = $3,994,268
  • 2026-02-13 — 225,000 @ $26.50 = $5,962,500
• Total sold: 1,225,784 shares for $32,658,518.
• Shares owned after the transactions: not specified in the provided extract.
• Footnote (F1): Manchester is a shareholder of QVT Financial Investment Cayman Ltd. (QVT FIC) but reportedly has no voting or investment control; he disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
• Filing info: Report filed Feb 13, 2026, reporting transactions dated Feb 11–13, 2026. No late-filing flag is indicated in the provided information.

Context
These were outright sales reported on a Form 4 (insider disposition). Sales by directors can be routine or for personal liquidity; the filing itself does not explain motivation. The filing indicates the shares were sold (S code) via open-market or private sale — not an exercise, gift, or award.